ViaDerma (ViaDerma) EPS (Basic) : $17.00 (TTM As of Jun. 2012)

View and export this data going back to 2008. Start your Free Trial

What is ViaDerma EPS (Basic)?

ViaDerma's basic earnings per share (Basic EPS) for the three months ended in Jun. 2012 was $7.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2012 was $17.00.

ViaDerma's EPS (Diluted) for the three months ended in Jun. 2012 was $7.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2012 was $17.00.

ViaDerma's EPS without NRI for the three months ended in Jun. 2012 was $7.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2012 was 17.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

ViaDerma EPS (Basic) Historical Data

The historical data trend for ViaDerma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma EPS (Basic) Chart

ViaDerma Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

EPS (Basic)

-12.60

49.50

30.50

33.00

19.50

ViaDerma Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12
EPS (Basic)	Get a 7-Day Free Trial															8.00	3.00	4.00	3.00	7.00

ViaDerma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

ViaDerma's Basic EPS for the fiscal year that ended in Dec. 2011 is calculated as

Basic EPS (A: Dec. 2011 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(2.673	-	0)	/	0.137
	=	19.51

ViaDerma's Basic EPS for the quarter that ended in Jun. 2012 is calculated as

Basic EPS (Q: Jun. 2012 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0.955	-	0)	/	0.137
	=	6.97

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $17.00

ViaDerma (OTCPK:VDRM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ViaDerma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of ViaDerma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

ViaDerma (ViaDerma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292

Website

https://www.viaderma.com

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.